Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-036131
Filing Date
2014-05-08
Accepted
2014-05-08 08:07:59
Documents
12
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a14-9604_110q.htm 10-Q 641995
2 EX-10.1 a14-9604_1ex10d1.htm EX-10.1 20803
3 EX-31.1 a14-9604_1ex31d1.htm EX-31.1 9793
4 EX-31.2 a14-9604_1ex31d2.htm EX-31.2 9280
5 EX-32.1 a14-9604_1ex32d1.htm EX-32.1 6487
6 EX-32.2 a14-9604_1ex32d2.htm EX-32.2 4313
  Complete submission text file 0001104659-14-036131.txt   5965412

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ovas-20140331.xml EX-101.INS 663112
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ovas-20140331.xsd EX-101.SCH 70068
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ovas-20140331_cal.xml EX-101.CAL 42178
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ovas-20140331_def.xml EX-101.DEF 355625
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ovas-20140331_lab.xml EX-101.LAB 1149187
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ovas-20140331_pre.xml EX-101.PRE 550435
Mailing Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142 617-500-2802
OvaScience, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35890 | Film No.: 14823070
SIC: 2834 Pharmaceutical Preparations